Examiners Amendment

LIQUIDIA

Liquidia Technologies, Inc.

U.S. Trademark Application Serial No. 90218085 - LIQUIDIA - 022214.017

To: Liquidia Technologies, Inc. (ip@wyrick.com)
Subject: U.S. Trademark Application Serial No. 90218085 - LIQUIDIA - 022214.017
Sent: June 24, 2021 04:23:21 PM
Sent As: ecom129@uspto.gov
Attachments:

United States Patent and Trademark Office (USPTO)

Office Action (Official Letter) About Applicant’s Trademark Application

 

U.S. Application Serial No. 90218085

 

Mark:  LIQUIDIA

 

 

        

 

Correspondence Address:  

       Devon E. White

       WYRICK ROBBINS YATES & PONTON LLP

       4101 LAKE BOONE TRAIL, SUITE 300

       RALEIGH, NC 27607

       

 

 

 

 

 

Applicant:  Liquidia Technologies, Inc.

 

 

 

Reference/Docket No. 022214.017

 

Correspondence Email Address: 

       ip@wyrick.com

 

 

 

EXAMINER’S AMENDMENT

 

 

Issue date:  June 24, 2021

 

 

USPTO database searched; no conflicting marks found.  The trademark examining attorney searched the USPTO database of registered and pending marks and found no conflicting marks that would bar registration under Trademark Act Section 2(d).  15 U.S.C. §1052(d); TMEP §704.02.

 

Application has been amended as shown below.  As agreed to by Devon White on 06/24/21, the examining attorney has amended the application as shown below.  Please notify the examining attorney immediately of any objections.  TMEP §707.  Otherwise, no response is required.  Id.  In addition, applicant is advised that amendments to the goods and/or services are permitted only if they clarify or limit them; amendments that add to or broaden the scope of the goods and/or services are not permitted.  37 C.F.R. §2.71(a).

 

The application is amended as follows:

 

Amended Identification of Goods/Services

 

Class 001:  Micro- and nano-particles, namely, those composed of polymers, excipients, therapeutics, and biologics used for the manufacture of medical and pharmaceutical goods and for general scientific and research purposes

 

Class 005:  Micro- and nano-particles, namely, those composed of polymers, excipients, therapeutics, and biologics used for medical diagnostic and treatment purposes; Micro- and nano-particles with prophylactic properties, namely, those composed of polymers, excipients, therapeutics, and biologics used for medical diagnostic and treatment purposes

 

Class 040:  Custom manufacture of micro- and nano-particles, namely, those composed of polymers, excipients, therapeutics, and biologics, for general scientific and research purposes; Custom manufacture of micro- and nano-particles, namely, those composed of polymers, excipients, therapeutics, and biologics used for the manufacture of medical and pharmaceutical goods and for general scientific and research purposes; custom manufacture of micro- and nano-particles, namely those composed of polymers, excipients, therapeutics, and biologics used for medical

 

/Nakia D. Henry/

Trademark Attorney (Law Office 129)

Phone:  (571) 272-7208

Fax:  (571) 273-7208

E-mail:  nakia.henry@uspto.gov

 

 


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed